Insecticides (India) Ltd
Insecticides (India) Ltd (INSECTICID) is scheduled to report results on 5 Nov 2026. Insecticides (India) Ltd last reported results for the quarter ended Jun 2026, with sales of ₹612 crore and net profit of ₹44 crore. The stock last traded at ₹580, a market capitalisation of ₹1,688 crore, on a P/E of 13.5. Over the past 52 weeks the stock has ranged between ₹519 and ₹776. Figures are as of 6 Oct 2026 and are not real time.
Insecticides (India) Ltd share price and key metrics
- Current price
- ₹580
- Market cap
- ₹1,688 cr
- Stock P/E
- 13.5
- Book value
- ₹419
- ROE
- 12.0%
- ROCE
- 15.8%
- Dividend yield
- 0.34%
- 52w high / low
- 776/519
Metrics as of 6 Oct 2026. Not real time.
Track Insecticides (India) Ltd
Cruxal reads every Insecticides (India) Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Insecticides (India) Ltd growth and returns
- 10 Years
- 9%
- 5 Years
- 9%
- 3 Years
- 6%
- TTM
- 1%
- 10 Years
- 13%
- 5 Years
- 6%
- 3 Years
- 30%
- TTM
- -17%
- 10 Years
- 6%
- 5 Years
- 4%
- 3 Years
- 4%
- 1 Year
- -22%
- 10 Years
- 13%
- 5 Years
- 11%
- 3 Years
- 12%
- Last Year
- 12%
Insecticides (India) Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹612 cr, down 11.4% from ₹691 cr a year earlier. Net profit was ₹44 cr, down 24.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 627 | 358 | 359 | 691 | 638 | 385 | 426 | 612 |
| Expenses | 538 | 327 | 330 | 607 | 548 | 358 | 401 | 544 |
| Operating profit | 90 | 31 | 28 | 85 | 89 | 27 | 25 | 68 |
| OPM % | 14% | 9% | 8% | 12% | 14% | 7% | 6% | 11% |
| Other income | 2 | 0 | 3 | 4 | 3 | 1 | 5 | 6 |
| Interest | 2 | 1 | 2 | 4 | 4 | 5 | 4 | 5 |
| Depreciation | 7 | 8 | 7 | 7 | 9 | 9 | 9 | 10 |
| Profit before tax | 82 | 22 | 22 | 77 | 79 | 14 | 16 | 59 |
| Tax % | 25% | 22% | 37% | 25% | 25% | 27% | 27% | 25% |
| Net profit | 61 | 17 | 14 | 58 | 59 | 10 | 12 | 44 |
| EPS (₹) | 21.13 | 5.97 | 4.77 | 19.97 | 20.31 | 3.61 | 4.02 | 15.08 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Insecticides (India) Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,140 | 2,060 |
| Operating profit | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 227 | 210 |
| OPM % | 11% | 14% | 16% | 11% | 11% | 11% | 7% | 8% | 11% | 11% | 10% |
| Net profit | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 139 | 125 |
| EPS (₹) | 19.26 | 27.19 | 39.62 | 28.04 | 30.29 | 36.29 | 21.36 | 34.49 | 48.81 | 47.91 | 43.02 |
TTM is the trailing twelve months to the most recent quarter.
Insecticides (India) Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| Reserves | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 982 | 1,056 | 1,191 |
| Borrowings | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 105 | 157 |
| Other liabilities | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 620 | 709 | 623 |
| Total liabilities | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 |
| Fixed assets | 185 | 232 | 240 | 239 | 239 | 253 | 263 | 286 | 282 | 370 |
| CWIP | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 130 |
| Investments | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 29 |
| Other assets | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,294 | 1,268 | 1,426 | 1,472 |
| Total assets | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 |
As reported by the company. Total assets equal total liabilities by construction.
Insecticides (India) Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 | 100 |
| Cash from investing | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 | -86 |
| Cash from financing | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 | 18 |
| Net cash flow | -0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 | 31 |
| Free cash flow | -10 | 154 | -171 | 213 | 108 | 68 | -97 | 143 | 59 | 8 |
| CFO / operating profit | 19% | 140% | -54% | 175% | 120% | 103% | 16% | 124% | 61% | 69% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Insecticides (India) Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 16% | 20% | 21% | 14% | 15% | 16% | 10% | 13% | 17% | 16% |
| Debtor days | 78 | 80 | 75 | 86 | 65 | 70 | 60 | 55 | 70 | 83 |
| Inventory days | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 221 | 268 | 215 |
| Days payable | 108 | 128 | 141 | 96 | 136 | 117 | 128 | 115 | 154 | 121 |
| Cash conversion cycle | 201 | 166 | 289 | 192 | 177 | 181 | 178 | 161 | 185 | 177 |
| Working capital days | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 97 | 106 | 105 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Insecticides (India) Ltd shareholding pattern
Promoters held 72.30% at Jun 2026, broadly unchanged since Jun 2025. FIIs 4.40% and DIIs 9.26%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.16% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% |
| FIIs | 5.43% | 5.13% | 4.50% | 4.65% | 4.51% | 4.46% | 4.50% | 4.40% |
| DIIs | 9.06% | 9.24% | 9.59% | 9.72% | 9.50% | 9.40% | 9.27% | 9.26% |
| Public | 13.36% | 13.34% | 13.63% | 13.32% | 13.69% | 13.85% | 13.94% | 14.04% |
| No. of shareholders | 22,484 | 22,849 | 22,688 | 21,436 | 22,336 | 22,359 | 22,274 | 21,380 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Insecticides (India) Ltd’s next results date?
Insecticides (India) Ltd’s next results are scheduled for 5 Nov 2026.
- Earnings resultsConsider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026
See the full results calendar for every Indian company reporting in the next 30 days.
Insecticides (India) Ltd corporate filings
- Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018Company Updatelow impact
- Insecticides (India) Limited schedules Q2 & H1 FY27 results announcement and earnings conference call for November 5, 2026Company Updatemedium impact
Cruxal's analysis: Insecticides (India) Limited has announced its financial results for Q2 and H1 FY27, with…
Read the full analysis - Insecticides (India) Limited maintains credit ratings at CRISIL A+/Stable (Long-Term) and CRISIL A1 (Short-Term) as of October 5, 2026Company Updatemedium impact
Cruxal's analysis: Insecticides (India) Limited has reaffirmed its existing credit ratings from CRISIL, with…
Read the full analysis - Closure of Trading Window and Intimation of Board Meeting for consideration of financial results for the quarter and half year ended September 30, 2026.Insider Trading / SASTlow impact
- Insecticides (India) Limited schedules Board Meeting for November 05, 2026, to approve Q2 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Insecticides (India) Limited has formally intimated the stock exchanges regarding a Board…
Read the full analysis - Insecticides (India) Ltd schedules analyst and institutional investor meetingsCompany Updatelow impact
Cruxal's analysis: Insecticides (India) Ltd has issued an intimation regarding upcoming analyst and…
Read the full analysis - Insecticides (India) Limited Q1 FY27 Earnings Call Transcript: Revenue Degrowth of 12% Amidst Challenging Agricultural SeasonCompany Updatemedium impact
Cruxal's analysis: Insecticides (India) Limited reported a challenging Q1 FY27 with revenue from operations…
Read the full analysis - Insecticides (India) Limited concludes 29th AGM; shareholders approve ESPS 2026 and dividendAGM/EGMmedium impact
Cruxal's analysis: Insecticides (India) Limited has successfully concluded its 29th Annual General Meeting…
Read the full analysis - Insecticides (India) Limited Concludes 29th AGM; Announces Appointment of Whole-time Director and Employee Stock Purchase SchemeAGM/EGMlow impact
Cruxal's analysis: Insecticides (India) Limited has successfully concluded its 29th Annual General Meeting…
Read the full analysis - Insecticides (India) Limited Reports Q1 FY2027 Financial ResultsCompany Updatelow impact
Cruxal's analysis: Insecticides (India) Limited has released its unaudited financial results for the first…
Read the full analysis - Insecticides (India) Limited releases audio recording of Q1 FY 2027 earnings conference callCompany Updatelow impact
Cruxal's analysis: Insecticides (India) Limited has formally disclosed the audio recording of its Q1 FY 2027…
Read the full analysis - Insecticides (India) Ltd releases press release for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: The company has filed a press release regarding its financial performance for the quarter…
Read the full analysis - Insecticides (India) Limited reports Q1 FY27 earnings with 12% YoY revenue decline and 24% YoY PAT contractionCompany Updatehigh impact
Cruxal's analysis: Insecticides (India) Limited released its Q1 FY27 results, showing a challenging quarter…
Read the full analysis - Insecticides (India) Limited Reports Q1 FY27 Financial Results with Significant YoY Profit DeclineBoard Meetinghigh impact
Cruxal's analysis: Insecticides (India) Limited reported Q1 FY27 standalone revenue from operations of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.